Cargando…

Antibody-mediated rejection with detection of de novo donor-specific anti-human leucocyte antigen Class II antibodies 3 years after heart transplantation: a case report

BACKGROUND: Antibody-mediated rejection (AMR) in cardiac transplantation may manifest early within the first weeks after transplantation but also late after months to years following transplantation resulting in mild heart failure to cardiogenic shock. While patients with early cardiac AMR are less...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ludwig, Bernd, Schneider, Johanna, Föll, Daniela, Zhou, Qian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047055/ https://www.ncbi.nlm.nih.gov/pubmed/32128488 http://dx.doi.org/10.1093/ehjcr/ytz246

Ejemplares similares

Clinical significance of de novo donor-specific antibody in kidney transplant recipients with chronic antibody-mediated rejection
por: Park, Woo Yeong, et al.
Publicado: (2021)

Role of de novo DQ donor-specific antibody in antibody-mediated rejection in renal transplant recipient: A case study
por: Chowdhry, Mohit, et al.
Publicado: (2019)

Belatacept Treatment of Recurrent Late-onset T Cell–mediated Rejection/Antibody-mediated Rejection With De Novo Donor-specific Antibodies in a Liver Transplant Patient
por: Klintmalm, Göran B., et al.
Publicado: (2022)

Characteristics of Donor-Specific Antibodies Associated With Antibody-Mediated Rejection in Lung Transplantation
por: Roux, Antoine, et al.
Publicado: (2017)

THE CHEMOTACTIC EFFECT OF MIXTURES OF ANTIBODY AND ANTIGEN ON POLYMORPHONUCLEAR LEUCOCYTES
por: Boyden, Stephen
Publicado: (1962)

Class and Kinetics of Weakly Reactive Pretransplant Donor-specific HLA Antibodies Predict Rejection in Kidney Transplant Recipients
por: Morrison, Alexander H., et al.
Publicado: (2019)

Donor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant Recipients
por: Jordan, Stanley C., et al.
Publicado: (2018)

Restricted dog leucocyte antigen (DLA) class II haplotypes and genotypes in Beagles
por: Soutter, Francesca, et al.
Publicado: (2015)

Feline leucocyte antigen class II polymorphism and susceptibility to feline infectious peritonitis
por: Addie, Diane D, et al.
Publicado: (2004)

Stillbirth rates and their association with swine leucocyte antigen class II haplotypes in Microminipigs
por: Imaeda, Noriaki, et al.
Publicado: (2021)

High tacrolimus intra-patient variability is associated with graft rejection, and de novo donor-specific antibodies occurrence after liver transplantation
por: Del Bello, Arnaud, et al.
Publicado: (2018)

Safety and efficacy of eculizumab for the prevention of antibody‐mediated rejection after deceased‐donor kidney transplantation in patients with preformed donor‐specific antibodies
por: Glotz, Denis, et al.
Publicado: (2019)

Antibody-Mediated Rejection in Kidney Transplantation: A Retrospective Study on the Impact of Donor-Specific Antibodies and on the Timing of Diagnosis
por: Reis Pereira, Pedro, et al.
Publicado: (2022)

Preformed Donor-specific Antibodies Against HLA Class II and Graft Outcomes in Deceased-donor Kidney Transplantation
por: Uffing, Audrey, et al.
Publicado: (2019)

Antibody-Mediated Rejection: An Evolving Entity in Heart Transplantation
por: Chih, Sharon, et al.
Publicado: (2012)

Massive induction of donor-type class I and class II major histocompatibility complex antigens in rejecting cardiac allografts in the rat
Publicado: (1985)

JC Polyomavirus Infection Is Strongly Controlled by Human Leucocyte Antigen Class II Variants
por: Sundqvist, Emilie, et al.
Publicado: (2014)

Combined Analysis of HLA Class II Eplet Mismatch and Tacrolimus Levels for the Prediction of De Novo Donor Specific Antibody Development in Kidney Transplant Recipients
por: Lee, Hyeyoung, et al.
Publicado: (2022)

Association between anti‐endothelial antigen antibodies and allograft rejection in kidney transplantation
por: Lee, Hyun Ji, et al.
Publicado: (2023)

Case Report: Splenic Irradiation for the Treatment of Chronic Active Antibody-Mediated Rejection in Kidney Allograft Recipients With De Novo Donor-Specific Antibodies
por: Zhu, Lan, et al.
Publicado: (2021)

Suppression of liver transplant rejection by anti-donor MHC antibodies via depletion of donor immunogenic dendritic cells
por: Ueta, Hisashi, et al.
Publicado: (2020)

Characterisation of breast cancer infiltrates using monoclonal antibodies to human leucocyte antigens.
por: Rowe, D. J., et al.
Publicado: (1984)

Detection of carcinoembryonic-like antigen on melanoma cells by leucocyte-dependent-antibody assays.
por: Morgan, G., et al.
Publicado: (1977)

Treatment of donor‐specific antibody‐mediated rejection after heart transplantation by IgM‐enriched human immunoglobulin
por: Immohr, Moritz Benjamin, et al.
Publicado: (2021)

Correction: JC Polyomavirus Infection Is Strongly Controlled by Human Leucocyte Antigen Class II Variants
Publicado: (2014)

Updates on antibody-mediated rejection in intestinal transplantation
por: Wu, Guo-Sheng
Publicado: (2016)

Antibody-mediated rejection after lung transplantation
por: Bery, Amit I., et al.
Publicado: (2020)

Association of intraindividual tacrolimus variability with de novo donor-specific HLA antibody development and allograft rejection in pediatric kidney transplant recipients with low immunological risk
por: Baghai Arassi, Maral, et al.
Publicado: (2022)

Antibodies against human platelet alloantigens and human leucocyte antigen class 1 in Saudi Arabian multiparous women and multi-transfused patients
por: Al-Ouda, Sarah K., et al.
Publicado: (2015)

Successful treatment of early acute antibody-mediated rejection in an human leukocyte antigen-incompatible and ABO-incompatible living-donor kidney transplant patient
por: Gang, Sujin, et al.
Publicado: (2019)

Donor-Derived Cell-Free DNA (ddcf-DNA) and Acute Antibody-Mediated Rejection in Kidney Transplantation
por: Jaikaransingh, Vishal, et al.
Publicado: (2021)

Incidence and Clinical Significance of De Novo Donor Specific Antibodies after Kidney Transplantation
por: Lionaki, Sophia, et al.
Publicado: (2013)

The natural history of de novo donor-specific HLA antibodies after kidney transplantation
por: López del Moral, Covadonga, et al.
Publicado: (2022)

Clinical significance of donor-specific anti-HLA-DR51/52/53 antibodies for antibody-mediated rejection in kidney transplant recipients
por: Park, Borae Geum, et al.
Publicado: (2019)

Combining donor-derived cell-free DNA and donor specific antibody testing as non-invasive biomarkers for rejection in kidney transplantation
por: Obrișcă, Bogdan, et al.
Publicado: (2022)

Circulating Donor Heart Exosome Profiling Enables Noninvasive Detection of Antibody-mediated Rejection
por: Hu, Robert W., et al.
Publicado: (2020)

Association of non-HLA antibodies against endothelial targets and donor-specific HLA antibodies with antibody-mediated rejection and graft function in pediatric kidney transplant recipients
por: Fichtner, Alexander, et al.
Publicado: (2021)

LIGHT/BTLA polymorphisms and antibody-mediated-rejection after heart transplantation
por: Marrón-Liñares, Grecia M., et al.
Publicado: (2018)

Relationship Between Human Leucocyte Antigen Class I and Class II and Chronic Idiopathic Urticaria Associated With Aspirin and/or NSAIDs Hypersensitivity
por: Pacor, Maria Luisa, et al.
Publicado: (2006)

Distribution of de novo Donor-Specific Antibody Subclasses Quantified by Mass Spectrometry: High IgG3 Proportion Is Associated With Antibody-Mediated Rejection Occurrence and Severity
por: Pernin, Vincent, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bb40hfl8k6s9k78kbqkl4vthuq